Crossmark

Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients

Crossref DOI link: https://doi.org/10.1038/s41598-022-13179-0

Published Online: 2022-06-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Voiriot, Guillaume

Dorgham, Karim

Bachelot, Guillaume

Fajac, Anne

Morand-Joubert, Laurence

Parizot, Christophe

Gerotziafas, Grigorios

Farabos, Dominique

Trugnan, Germain

Eguether, Thibaut

Blayau, Clarisse

Djibré, Michel

Elabbadi, Alexandre

Gibelin, Aude

Labbé, Vincent

Parrot, Antoine

Turpin, Matthieu

Cadranel, Jacques

Gorochov, Guy

Fartoukh, Muriel

Lamazière, Antonin
License Information

Text and Data Mining valid from 2022-06-09

Version of Record valid from 2022-06-09
More Information

Article History

Received: 13 December 2021

Accepted: 20 May 2022

First Online: 9 June 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below